🇺🇸 FDA
Pipeline program

Hiconcil 500 mg trde kapsule, Enterol 250 mg, gélules, Matched Placebo will consist in caspules similar to the 250 mg capsules of the Saccharomyces boulardii CNCM-I-745 but with no active ingredient

Sb 241

Approved small_molecule active

Quick answer

Hiconcil 500 mg trde kapsule, Enterol 250 mg, gélules, Matched Placebo will consist in caspules similar to the 250 mg capsules of the Saccharomyces boulardii CNCM-I-745 but with no active ingredient for Patients undergoing antibiotic therapy (in the context of erythema migrans (early skin form of Lyme borreliosis)) is a Approved program (small_molecule) at Biocodex with 1 ClinicalTrials.gov record(s).

Program details

Company
Biocodex
Indication
Patients undergoing antibiotic therapy (in the context of erythema migrans (early skin form of Lyme borreliosis))
Phase
Approved
Modality
small_molecule
Status
active

Clinical trials